Skip to main content

Table 4 The antibiotic susceptibilities of the Streptococcus pneumoniae isolates

From: Serotypes distribution and antibiotic susceptibility of Streptococcus pneumoniae strains: five-year surveillance results of post-PCV-13

 

Invasive n (%)

Non-invasive n (%)

Antimicrobial Agents

 

S

I

R

Total

S

I

R

Total

Penicillin

Oral

14 (32.6)

22 (51.2)

7 (16.2)

43 (100)

110 (29.2)

183 (48.5)

84 (22.3)

377 (100)

Parenteral

(for non-meningitis)

38 (88.4)

5 (11.6)

0 (0)

43 (100)

321 (85.1)

41 (10.9)

15 (4)

377 (100)

Parenteral

(for meningitis)

19 (44.2)

0 (0)

24 (55.8)

43 (100)

123 (32.6)

0 (0)

254 (67.4)

377 (100)

Ceftriaxone

Parenteral

(for non-meningitis)

34 (79.1)

7 (16.2)

2 (4.7)

43 (100)

311 (82.5)

47 (12.5)

19 (5)

377 (100)

Parenteral

(for meningitis)

33 (76.7)

4 (9.3)

6 (14)

43 (100)

253 (67.1)

79 (21)

45 (11.9)

377 (100)

Erythromycin

 

24 (55.8)

1 (2.3)

18 (41.9)

43 (100)

149 (39.5)

12 (3.2)

216 (57.3)

377 (100)

TMP-SMX

 

24 (55.8)

4 (9.3)

15 (34.9)

43 (100)

224 (59.4)

29 (7.7)

124 (32.9)

377 (100)

Vancomycin

 

43 (100)

0 (0)

0 (0)

43 (100)

375 (99.5)

0 (0)

2 (0.5)

377 (100)

Tetracycline

 

20 (48.8)

7 (17.1)

14 (34.1)

41 (100)

113 (31.7)

44 (12.3)

200 (56)

357 (100)

Chloramphenicol

 

38 (90.5)

0 (0)

4 (9.5)

42 (100)

308 (90.1)

0 (0)

34 (9.9)

342 (100)

Rifampin

 

41 (97.6)

0 (0)

1 (2.4)

42 (100)

335 (99.1)

0 (0)

3 (0.9)

338 (100)

Clindamycin

 

28 (75.7)

0 (0)

9 (24.3)

37 (100)

196 (58.2)

3 (0.9)

138 (40.9)

337 (100)

Levofloxacin

 

43 (100)

0 (0)

0 (0)

43 (100)

321 (98.8)

1 (0.3)

3 (0.9)

325 (100)

Moxifloxacin

 

31 (100)

0 (0)

0 (0)

31 (100)

227 (97.8)

0 (0)

5 (2.2)

232 (100)

  1. S: sensitive, I: intermediate; R: resistance; TMP-SMX: Trimethoprim-sulfamethoxazole